BIO

MKT CAP:$8B

Bio-Rad Laboratories Inc

Market Cap

$8B

Healthcare·Medical Devices·🇺🇸 United States·NYSE

Healthcare·Medical Devices·🇺🇸·NYSE

Stock Price

$291.31-$13.96 (-4.57%)

Jun 8, 2026

52W High $339.7552W Low $225.56

Company Details

Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life...

CEO

—

IPO Date

Jan 1, 1966

Website

www.bio-rad.com

Key Metrics TTM

Revenue

$2.6B

+1.9% YoY

Net Income

$169M

EPS (Diluted)

Free Cash Flow

$357M

Revenue / Share

$96.07

Gross Margin

51.9%

Operating Margin

9.2%

Net Margin

6.5%

FCF Margin

13.8%

P/S

3.2x

P/E

48.4x

Earnings Reports

Q2 2026

Jul 30, 2026

PENDING

Q1 2026

Apr 30, 2026

$592M+1.1%

FY 2025

Feb 13, 2026

$2.6B+0.7%

Q4 2025

Feb 13, 2026

$693M+3.9%

Q3 2025

Oct 29, 2025

$653M+0.5%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee